Derk Jan de Groot
Rijksuniversiteit Groningen
H-index: 24
Europe-Netherlands
Top articles of Derk Jan de Groot
Trastuzumab plus Pertuzumab for HER2-amplified Advanced Colorectal Cancer: Results from the Drug Rediscovery Protocol (DRUP)
European Journal of Cancer
2024/5/1
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial
JAMA surgery
2024/2/14
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
BMC cancer
2023/8/7
Opportunities on the horizon for the management of early colon cancer
2023/3/1
Self‐Targeted Co‐Delivery of an Antibiotic and a Cancer‐Chemotherapeutic from Synthetic Liposomes for the Treatment of Infected Tumors
Advanced Functional Materials
2023/8
Nationwide implementation of best practices in pancreatic cancer care: stepped-wedge cluster RCT
HPB
2023/1/1
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a …
The Lancet
2023/6/3
Changhoon Yoo
H-Index: 23
Li Yu
H-Index: 2
Ivan Borbath
H-Index: 25
Giovanni Brandi
H-Index: 35
Ke Cao
H-Index: 2
Xiaoming Chen
H-Index: 20
Sarah Davis
H-Index: 23
Maria Diab
H-Index: 8
Olumide Gbolahan
H-Index: 9
Chiun Hsu
H-Index: 32
Jong Gwang Kim
H-Index: 18
Choong-Kun Lee
H-Index: 12
Hyun Woo Lee
H-Index: 8
Wei Li
H-Index: 8
David Malka
H-Index: 5
Ray Mcdermott
H-Index: 21
Bruno Nervi
H-Index: 14
Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma
Cancer medicine
2023/6
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer
2023/5/8
Daan Knapen
H-Index: 3
Derk Jan De Groot
H-Index: 14
Elisabeth De Vries
H-Index: 68
Arkajyoti Bhattacharya
H-Index: 3
LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy
Cancer Research
2023/4/4
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
2023/4/1
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol
The Oncologist
2023/12/18
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations
Molecular Imaging and Biology
2023/4
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
Nature Medicine
2022/12
89Zr-3, 2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice
Journal of Nuclear Medicine
2022/11/1
A Phase 1 Open-Label, Dose Escalation and Expansion Trial to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of CB307, a Trispecific Humabody® T-cell Enhancer, in …
prostate
2022/6/15
Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy
European Journal of Hybrid Imaging
2022/6/15
Abstract CT207: A phase 1 open-label, dose escalation and expansion trial to investigate the safety, pharmacokinetics and pharmacodynamics of CB307, a Trispecific Humabody® T …
Cancer Research
2022/6/15
Patients with rare cancers in the drug rediscovery protocol (DRUP) benefit from genomics-guided treatment
Clinical Cancer Research
2022/4/1
Anne Ml Jansen
H-Index: 7
Erik Van Werkhoven
H-Index: 30
Derk Jan De Groot
H-Index: 14
Mariette Labots
H-Index: 15
Hans Gelderblom
H-Index: 65
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial
Therapeutic advances in medical oncology
2022/2
Co-Authors
